Search

Sabat, Robert, Gregor B E Jemec, Łukasz Matusiak, Alexa B Kimball, Errol Prens, and Kerstin Wolk. 2020. “Hidradenitis Suppurativa.”. Nature Reviews. Disease Primers 6 (1): 18.

Savage, Kevin T, Monica Rosales Santillan, Kelsey S Flood, Alexandra Charrow, Martina L Porter, and Alexa B Kimball. 2020. “Tofacitinib Shows Benefit in Conjunction With Other Therapies in Recalcitrant Hidradenitis Suppurativa Patients.”. JAAD Case Reports 6 (2): 99-102.

Savage, Kevin T, Kelsey S Flood, Martina L Porter, and Alexa B Kimball. 2019. “TNF-α Inhibitors in the Treatment of Hidradenitis Suppurativa.”. Therapeutic Advances in Chronic Disease 10: 2040622319851640.

Kimball, Alexandra B, Murali Sundaram, Genevieve Gauthier, Annie Guérin, Irina Pivneva, Rakesh Singh, and Arijit Ganguli. 2018. “The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis.”. Dermatology and Therapy 8 (4): 557-69.

Bae, Yoon-Soo Cindy, Abby S Van Voorhees, Sylvia Hsu, Neil J Korman, Mark G Lebwohl, Melody Young, Bruce Bebo, Alexa Boer Kimball, and National Psoriasis Foundation. 2012. “Review of Treatment Options for Psoriasis in Pregnant or Lactating Women: From the Medical Board of the National Psoriasis Foundation.”. Journal of the American Academy of Dermatology 67 (3): 459-77.

Kimball, Alexa B, Philippe Szapary, Ulrich Mrowietz, Kristian Reich, Richard G Langley, Yin You, Ming-Chun Hsu, Newman Yeilding, Daniel J Rader, and Nehal N Mehta. 2012. “Underdiagnosis and Undertreatment of Cardiovascular Risk Factors in Patients With Moderate to Severe Psoriasis.”. Journal of the American Academy of Dermatology 67 (1): 76-85.

Latham, Lesley, Aimee MacDonald, Alexa B Kimball, and Richard G Langley. 2012. “Teaching Empathy to Undergraduate Medical Students Using a Temporary Tattoo Simulating Psoriasis.”. Journal of the American Academy of Dermatology 67 (1): 93-9.

Kimball, Alexa B, Dafna Gladman, Joel M Gelfand, Kenneth Gordon, Elizabeth J Horn, Neil J Korman, Gretchen Korver, et al. 2008. “National Psoriasis Foundation Clinical Consensus on Psoriasis Comorbidities and Recommendations for Screening.”. Journal of the American Academy of Dermatology 58 (6): 1031-42.

Leonardi, Craig L, Alexa B Kimball, Kim A Papp, Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Shu Li, Lisa T Dooley, Kenneth B Gordon, and PHOENIX 1 study investigators. 2008. “Efficacy and Safety of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Psoriasis: 76-Week Results from a Randomised, Double-Blind, Placebo-Controlled Trial (PHOENIX 1).”. Lancet (London, England) 371 (9625): 1665-74.

Kimball, Alexa B, Kenneth B Gordon, Richard G Langley, Alan Menter, Elliot K Chartash, Joaquin Valdes, and ABT-874 Psoriasis Study Investigators. 2008. “Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis: Results of a Randomized, Placebo-Controlled, Phase 2 Trial.”. Archives of Dermatology 144 (2): 200-7.